MedTrace Logo

Genetic Markers in Patients With Colorectal Cancer

NCT00014079 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 675

Last updated 2016-07-13

No results posted yet for this study

Summary

RATIONALE: Determination of genetic markers for colorectal cancer may improve the identification of patients who are at highest risk for relapse.

PURPOSE: This clinical trial is studying the importance of genetic markers for detecting relapse in patients with colorectal cancer.

Conditions

Interventions

GENETIC

DNA stability analysis

GENETIC

loss of heterozygosity analysis

GENETIC

microsatellite instability analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Steven R. Alberts, MD · Mayo Clinic

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-09-30
Primary Completion
2003-07-31
Completion
2005-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00014079 on ClinicalTrials.gov